Cancer Care Gaps Persist for Incarcerated People: A Deep Dive into the Disparity
In the United States, the incarcerated population is aging, with approximately 15% of adults, or around 175,000 individuals, now aged 55 or older. As this demographic ages, cancer has emerged as a significant health concern, posing a grave threat to their well-being.
Despite the increasing prevalence of cancer among incarcerated individuals, the outcomes are starkly contrasting. A recent study conducted by Yale researchers reveals that cancer care for those diagnosed during or shortly after incarceration falls short of the recommended standards, contributing to the disparity in mortality rates.
The study, published in JAMA Network Open, delves into the quality of cancer care received by individuals diagnosed with cancer while incarcerated or shortly after release. It highlights a concerning trend: those diagnosed during incarceration or soon after release were less likely to receive timely, guideline-recommended cancer treatment.
"Incarceration is linked to higher cancer-related mortality," stated Cary Gross, a professor at Yale School of Medicine. "Given the constitutional right to care for incarcerated individuals, understanding the cancer care they receive is crucial."
Previous research has associated incarceration with poor cancer outcomes, but the study sheds light on the quality of care among those with an incarceration history. Ilana Richman, an assistant professor at Yale, emphasizes the importance of addressing barriers to high-quality, timely care for incarcerated individuals.
The outsourcing of specialized cancer care, including oncologic treatment, presents both advantages and challenges. On one hand, patients can access comprehensive cancer centers and academic facilities, renowned for their cutting-edge treatments and superior outcomes. However, this outsourcing also introduces obstacles, from scheduling complexities to transportation arrangements. Additionally, government financing for carceral healthcare may lead to budget constraints, influencing the quality of care.
To investigate further, the researchers analyzed data from Connecticut's cancer registry and correctional department rosters, identifying individuals diagnosed with invasive cancer from 2005 to 2016. They categorized patients into three groups: those diagnosed during incarceration, those diagnosed within 12 months after release, and those with no incarceration history. The study, encompassing 690 individuals, was conducted from March 2024 to January 2025.
The researchers assessed various indicators of care quality, including treatment initiation time and adherence to recommended cancer care. They found that patients diagnosed during incarceration were less likely to receive timely treatment and recommended care. Similarly, those diagnosed shortly after release faced challenges in accessing timely, guideline-recommended treatment.
"Our community members often know someone with a criminal justice history," Gross noted. "This study underscores the need to improve the health of these individuals and consider the broader impact of mass incarceration. As we develop new cancer screening and treatment methods, ensuring accessibility is vital."
The findings suggest that care quality gaps may contribute to the observed disparities in cancer outcomes among those with an incarceration history. The research team is currently conducting interviews with incarcerated cancer patients to gather firsthand accounts of their experiences.
Gross, the founder of the Yale Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, and Richman, a COPPER affiliate, led the study. Other contributors included Lisa Puglisi, Rajni Mehta, Emily Wang, Jenerius Aminawung, and Jason Weinstein, a medical student.
The study received support from the National Institutes of Health, emphasizing the importance of addressing cancer care disparities within the incarcerated population.
